Immune Checkpoint Inhibitors and Survival Outcomes in Brain Metastasis: A Time Series-Based Meta-Analysis

Immune Checkpoint Inhibitors and Survival Outcomes in Brain Metastasis: A Time Series-Based Meta-Analysis

Immune checkpoint inhibitors (ICIs) have shown potential to improve the prognosis of patients with brain metastasis (BM) caused by advanced cancers. However, controversies still exist in regard to its survival benefits. In the present work, a time series-based meta-analysis based on the phase I/II/I...

Full description

Bibliographic Details
Main Authors:	Xingjiang Hu, Hui Yu, Yunliang Zheng, Qiao Zhang, Meihua Lin, Jialei Wang, Yunqing Qiu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-10-01
Series:	Frontiers in Oncology
Subjects:	immune checkpoint inhibitor brain metastasis survival prognosis meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2020.564382/full

Similar Items

Visceral Metastasis: A Prognostic Factor of Survival in Patients with Spinal Metastases
by: Deng‐xing Lun, et al.
Published: (2020-04-01)

Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies
by: Elham Vosoughi, et al.
Published: (2018-04-01)

Clinical Research on the Mechanisms Underlying Immune Checkpoints and Tumor Metastasis
by: Xi-Yang Tang, et al.
Published: (2021-07-01)

Risk Factors for Lymph Node Metastasis and Survival Outcomes in Colorectal Neuroendocrine Tumors
by: Wu Z, et al.
Published: (2020-08-01)

Metastatic breast cancer: clinicopathological features and survival according to the site of metastasis
by: Igor Vilela Brum, et al.
Published: (2017-06-01)

Correlation and Survival Analysis of Distant Metastasis Site and Prognosis in Patients With Hepatocellular Carcinoma
by: Hao Zhan, et al.
Published: (2021-05-01)

Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma
by: Lei Zhang, et al.
Published: (2019-12-01)

Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma
by: Lin Yang, et al.
Published: (2017-09-01)

A Nomogram for Predicting Survival in Patients With Breast Cancer Liver Metastasis: A Population-Based Study
by: Yu Xiong, et al.
Published: (2021-06-01)

The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: a systematic review and meta-analysis
by: Wen-Ya Li, et al.
Published: (2019-02-01)

Second Primary Cancers in Melanoma Patients Critically Shorten Survival
by: Zheng G, et al.
Published: (2020-01-01)

A novel gene signature based on five immune checkpoint genes predicts the survival of glioma
by: Wei Zhang, et al.
Published: (2021-02-01)

Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas
by: Laubert Tilman, et al.
Published: (2012-03-01)

Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer Patients With Different Metastatic Sites: A Systematic Review and Meta-Analysis
by: Kaili Yang, et al.
Published: (2020-07-01)

The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer
by: Jiayan Wei, et al.
Published: (2021-10-01)

A risk stratification model for predicting brain metastasis and brain screening benefit in patients with metastatic triple‐negative breast cancer
by: Mingxi Lin, et al.
Published: (2020-11-01)

Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinoma
by: Ying Xu, et al.
Published: (2021-01-01)

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis
by: Elias A. T. Koch, et al.
Published: (2021-07-01)

Survival of Patients Treated with Antibiotics and Immunotherapy for Cancer: A Systematic Review and Meta-Analysis
by: Fausto Petrelli, et al.
Published: (2020-05-01)

Metastasis Patterns and Prognosis of Elderly Patients With Esophageal Adenocarcinoma in Stage IVB: A Population-Based Study
by: Guanghao Qiu, et al.
Published: (2021-05-01)

Usefulness of IMP3 and FOXP3 to predict metastasis of cutaneous melanomas
by: Juliana Polizel Ocanha-Xavier, et al.
Published: (2018-10-01)

Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy
by: John M. Rieth, et al.
Published: (2021-03-01)

A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma
by: Dina Guo, et al.
Published: (2020-03-01)

Adult primary prostate sarcoma: A multi-center cohort study and comparison between Chinese and American cases
by: Beichen Ding, et al.
Published: (2021-01-01)

Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
by: Li J, et al.
Published: (2021-03-01)

Long-term survival after repeated resection for lung metastasis originating from pancreatic cancer: a case report
by: Yasunori Uesato, et al.
Published: (2020-04-01)

Age, pathology and CA-125 are prognostic factors for survival in patients with brain metastases from gynaecological tumours
by: S.H.J. Nagtegaal, et al.
Published: (2020-09-01)

The role of SRGN in the survival and immune infiltrates of skin cutaneous melanoma (SKCM) and SKCM-metastasis patients
by: Xiaofang Wang, et al.
Published: (2020-05-01)

Antibiotic therapy and outcome from immune-checkpoint inhibitors
by: David J. Pinato, et al.
Published: (2019-11-01)

Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson
by: Yinghong Wang, et al.
Published: (2018-05-01)

Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan
by: Hisanaga K, et al.
Published: (2021-02-01)

Analysis of survival in patients with brain metastases treated surgically: Impact of age, gender, oncologic status, chemotherapy, radiotherapy, number and localization of lesions, and primary cancer site
by: José Marcus Rotta, et al.

Prognostic value of serum alkaline phosphatase in the survival of prostate cancer: evidence from a meta-analysis
by: Li D, et al.
Published: (2018-08-01)

Identification of immune subtypes and prognosis of hepatocellular carcinoma based on immune checkpoint gene expression profile
by: Dafeng Xu, et al.
Published: (2020-06-01)

Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]
by: Hisanaga K, et al.
Published: (2021-07-01)

Prognostic and clinical significance of focal adhesion kinase expression in breast cancer: A systematic review and meta-analysis
by: Weiqiang Qiao, et al.
Published: (2020-11-01)

Research Advances in Intracranial Radiotherapy Combined with Immune Checkpoint Inhibitors on Lung Cancer Brain Metastasis
by: HE Qian, et al.
Published: (2020-04-01)

Association between body mass index and survival outcomes for cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
by: Yue An, et al.
Published: (2020-06-01)

Immune checkpoints bone marrow expression as the predictor of clinical outcome in myelodysplastic syndrome
by: Nikolai Tcvetkov, et al.
Published: (2020-01-01)

Prognostic impacts of extracranial metastasis on non‐small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database
by: Miao Wang, et al.
Published: (2021-01-01)